Андрей Евгеньевич Баев
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Андрей Евгеньевич Баев has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Alla Yu. Falkovskaya
Cardiology Research Institute, Tomsk National Research Medical Center (Cardiology Research Institute, Tomsk NRMC), Russian Academy of Sciences
17 shared publications - Stanislav Pekarskiy
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia (Cardiology Research Institute, TNRMC)
16 shared publications - Viktor Fedorovich Mordovin
Cardiology Research Institute, Tomsk National Research Medical Center (Cardiology Research Institute, Tomsk NRMC), Russian Academy of Sciences
15 shared publications - Irina Vladimirovna Zyubanova
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences (Cardiology Research Institute, Tomsk NRMC)
14 shared publications - Valeria A. Lichikaki
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences (Cardiology Research Institute, Tomsk NRMC)
14 shared publications А. Ю. Фальковская
Научно-исследовательский институт кардиологии, Томский национальный исследовательский медицинский центр Российской академии наук (НИИ кардиологии Томского НИМЦ)
12 shared publications
Latest Publications
- Open Access
- 2 October 2026
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 41 (3) , 148-154
Potential anatomical predictors of in-hospital complications following transfemoral aortic valve replacement with the MedInzh prosthesis: a pilot study
Until recently, the only transcatheter synthetic aortic prostheses available on the Russian market were those with transapical or transaortic delivery systems. A synthetic prosthesis with a novel transfemoral delivery system has been developed in our country; however, the literature contains no data on the results of its use. Aim: To assess the incidence of in-hospital complications in the early postoperative period following transcatheter aortic valve replacement (TAVR) with the MedInzh prosthesis in patients with degenerative aortic valve stenosis, based on multislice computed tomography (panaortography) data (MSCT), and to identify their potential anatomical predictors. Material and methods. This clinical trial is a prospective, single-center pilot study included patients with confirmed severe aortic stenosis: effective aortic valve orifice area of ≤ 1.0 cm²; mean transvalvular gradient ≥ 40 mmHg. All patients underwent transfemoral valve replacement for correction of severe degenerative aortic stenosis using the synthetic MedInzh prosthesis. All procedures were performed between 2023 and 2025. Results. A total of 30 patients at moderate and high surgical risk were enrolled; median age was 75 (68.5; 77.5) years; 27% were male. The incidence of in-hospital complications was 27% (acute cerebrovascular accident 7%; ventricular arrhythmias 7%; acute common iliac artery thrombosis 7%; acute myocardial ischemia 3%; lymphocele 3%). The odds of complications after TAVR increased when the minimal diameter of the common iliac artery on the access side was ≤ 10.5 mm (OR = 19.2; 95% CI: 1.844–199.9); with the longitudinal diameter of the external iliac artery was ≤ 7.75 mm (OR = 25.5; 95% CI: 2.5–276); and with a transverse diameter was ≤ 8.2 mm (OR = 8; 95% CI: 1.2–55). Conclusions. Among intermediate- and high-risk patients with severe symptomatic aortic stenosis undergoing transfemoral aortic valve replacement with the MedInzh prosthesis, the rate of in-hospital complications was 27%, with vascular complications accounting for 7%. MSCT panaortography results suggest that the diameter of the common iliac arteries, the minimal diameter of the common iliac artery, and the longitudinal and transverse diameters of the external iliac arteries on the access side are potential anatomical predictors associated with the development of vascular complications after TAVR.
- 2 October 2026
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 41 (3) , 148-154
Open AccessPotential anatomical predictors of in-hospital complications following transfemoral aortic valve replacement with the MedInzh prosthesis: a pilot study
Until recently, the only transcatheter synthetic aortic prostheses available on the Russian market were those with transapical or transaortic delivery systems. A synthetic prosthesis with a novel transfemoral delivery system has been developed in our country; however, the literature contains no data on the results of its use. Aim: To assess the incidence of in-hospital complications in the early postoperative period following transcatheter aortic valve replacement (TAVR) with the MedInzh prosthesis in patients with degenerative aortic valve stenosis, based on multislice computed tomography (panaortography) data (MSCT), and to identify their potential anatomical predictors. Material and methods. This clinical trial is a prospective, single-center pilot study included patients with confirmed severe aortic stenosis: effective aortic valve orifice area of ≤ 1.0 cm²; mean transvalvular gradient ≥ 40 mmHg. All patients underwent transfemoral valve replacement for correction of severe degenerative aortic stenosis using the synthetic MedInzh prosthesis. All procedures were performed between 2023 and 2025. Results. A total of 30 patients at moderate and high surgical risk were enrolled; median age was 75 (68.5; 77.5) years; 27% were male. The incidence of in-hospital complications was 27% (acute cerebrovascular accident 7%; ventricular arrhythmias 7%; acute common iliac artery thrombosis 7%; acute myocardial ischemia 3%; lymphocele 3%). The odds of complications after TAVR increased when the minimal diameter of the common iliac artery on the access side was ≤ 10.5 mm (OR = 19.2; 95% CI: 1.844–199.9); with the longitudinal diameter of the external iliac artery was ≤ 7.75 mm (OR = 25.5; 95% CI: 2.5–276); and with a transverse diameter was ≤ 8.2 mm (OR = 8; 95% CI: 1.2–55). Conclusions. Among intermediate- and high-risk patients with severe symptomatic aortic stenosis undergoing transfemoral aortic valve replacement with the MedInzh prosthesis, the rate of in-hospital complications was 27%, with vascular complications accounting for 7%. MSCT panaortography results suggest that the diameter of the common iliac arteries, the minimal diameter of the common iliac artery, and the longitudinal and transverse diameters of the external iliac arteries on the access side are potential anatomical predictors associated with the development of vascular complications after TAVR.
- 30 September 2026
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 15 (3)
Increased Plasma Mitochondrial DNA Copy Number and Association with Complications after Coronary Artery Bypass Grafting: Results of a Pilot Cohort Study
Objective — To determine the mitochondrial DNA (mtDNA) copy number in the blood of patients before and within 10 days after coronary artery bypass grafting (CABG) and to evaluate the association between mtDNA copy number and postoperative complications. Methods — This single-center, prospective, unblinded cohort study included 26 patients undergoing CABG with a median age of 67 years (interquartile range [IQR]: 58-71). Plasma and peripheral blood mononuclear cells (PBMCs) were collected from patients before CABG and at 3, 5, 7, and 10 days after CABG. MtDNA copy number was measured using digital polymerase chain reaction. Results — In plasma, the median mtDNA copy number in million copies per mL was 5.12 (3.35-7.44) before CABG, 2.65 (1.88-3.04) on Day 3, 4.04 (2.28-7.00) on Day 5, 6.50 (3.47-11.31) on Day 7, and 10 (7.2-13.4) on Day 10. The median mtDNA copy number in PBMCs was 79 (63.5-95.2) copies/cell before CABG; it did not change statistically significantly after CABG (p>0.05). Patients with complications had a significant increase in plasma mtDNA copy number (198%; IQR: 101; 321) vs. patients without complications (11%; IQR: -36; 127%; p=0.008). Conclusion — Based on the results of our pilot study, an increase in mtDNA copy number by Day 10 after CABG is associated with postoperative complications. The mtDNA copy number in PBMCs did not change significantly after CABG.
- 30 September 2026
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 15 (3)
Increased Plasma Mitochondrial DNA Copy Number and Association with Complications after Coronary Artery Bypass Grafting: Results of a Pilot Cohort Study
Objective — To determine the mitochondrial DNA (mtDNA) copy number in the blood of patients before and within 10 days after coronary artery bypass grafting (CABG) and to evaluate the association between mtDNA copy number and postoperative complications. Methods — This single-center, prospective, unblinded cohort study included 26 patients undergoing CABG with a median age of 67 years (interquartile range [IQR]: 58-71). Plasma and peripheral blood mononuclear cells (PBMCs) were collected from patients before CABG and at 3, 5, 7, and 10 days after CABG. MtDNA copy number was measured using digital polymerase chain reaction. Results — In plasma, the median mtDNA copy number in million copies per mL was 5.12 (3.35-7.44) before CABG, 2.65 (1.88-3.04) on Day 3, 4.04 (2.28-7.00) on Day 5, 6.50 (3.47-11.31) on Day 7, and 10 (7.2-13.4) on Day 10. The median mtDNA copy number in PBMCs was 79 (63.5-95.2) copies/cell before CABG; it did not change statistically significantly after CABG (p>0.05). Patients with complications had a significant increase in plasma mtDNA copy number (198%; IQR: 101; 321) vs. patients without complications (11%; IQR: -36; 127%; p=0.008). Conclusion — Based on the results of our pilot study, an increase in mtDNA copy number by Day 10 after CABG is associated with postoperative complications. The mtDNA copy number in PBMCs did not change significantly after CABG.
- Open Access
- 11 February 2026
- Published by APO Society of Specialists in Heart Failure in Kardiologiia
- Vol. 66 (1) , 3-16
Stress Echocardiography with Advanced Protocol for Evaluation of Hemodynamic Significant Coronary Stenosis and Different Phenotypes of Chronic Coronary Syndromes
Aim: To evaluate the feasibility of stress echocardiography (stress-ECHO) with an extended protocol in the diagnosis of hemodynamically significant coronary artery disease (CAD) and in the differential diagnosis of different phenotypes of chronic coronary syndromes. Material and methods: This observational study enrolled 454 patients (60.79% men, mean age 61.2±9.8 years) with established (n=191; 42.07%) or suspected (n=263; 57.93%) ischemic heart disease (IHD). The stress-ECHO protocol assessed left ventricular (LV) regional wall motion abnormalities (RWMA) (A), B-lines (B), contractile reserve (LVCR) (C), coronary flow reserve (CFR) (D), heart rate (HR) reserve (E), global longitudinal strain (GLS), and diastolic function. Based on multislice computed tomography/coronary angiography with fractional flow reserve (if necessary), patients were categorized into four phenotypes: Group 0, non-obstructive hemodynamically insignificant CAD (conditional normal; n=118; 26.0%); Group 1, non-obstructive hemodynamically significant CAD (microvascular IHD; n=84; 18.5%); Group 2, obstructive hemodynamically insignificant CAD (obstructive coronary atherosclerosis; n=107; 23.6%); and Group 3, obstructive hemodynamically significant CAD (obstructive IHD; n=145; 31.9%). Significance was set at p=0.05. Results: The groups differed significantly in maximum CAD percentage (pConclusion: The extended ABCDE stress-ECHO protocol in a modern cohort of individuals with chest pain reliably identifies hemodynamically significant CAD, but fails to differentiate between obstructive and non-obstructive lesions. Differentiation based on the severity of CA damage was only possible using a peak stress LV GLS
- 11 February 2026
- Published by APO Society of Specialists in Heart Failure in Kardiologiia
- Vol. 66 (1) , 3-16
Open AccessStress Echocardiography with Advanced Protocol for Evaluation of Hemodynamic Significant Coronary Stenosis and Different Phenotypes of Chronic Coronary Syndromes
Aim: To evaluate the feasibility of stress echocardiography (stress-ECHO) with an extended protocol in the diagnosis of hemodynamically significant coronary artery disease (CAD) and in the differential diagnosis of different phenotypes of chronic coronary syndromes. Material and methods: This observational study enrolled 454 patients (60.79% men, mean age 61.2±9.8 years) with established (n=191; 42.07%) or suspected (n=263; 57.93%) ischemic heart disease (IHD). The stress-ECHO protocol assessed left ventricular (LV) regional wall motion abnormalities (RWMA) (A), B-lines (B), contractile reserve (LVCR) (C), coronary flow reserve (CFR) (D), heart rate (HR) reserve (E), global longitudinal strain (GLS), and diastolic function. Based on multislice computed tomography/coronary angiography with fractional flow reserve (if necessary), patients were categorized into four phenotypes: Group 0, non-obstructive hemodynamically insignificant CAD (conditional normal; n=118; 26.0%); Group 1, non-obstructive hemodynamically significant CAD (microvascular IHD; n=84; 18.5%); Group 2, obstructive hemodynamically insignificant CAD (obstructive coronary atherosclerosis; n=107; 23.6%); and Group 3, obstructive hemodynamically significant CAD (obstructive IHD; n=145; 31.9%). Significance was set at p=0.05. Results: The groups differed significantly in maximum CAD percentage (pConclusion: The extended ABCDE stress-ECHO protocol in a modern cohort of individuals with chest pain reliably identifies hemodynamically significant CAD, but fails to differentiate between obstructive and non-obstructive lesions. Differentiation based on the severity of CA damage was only possible using a peak stress LV GLS
- Open Access
- 18 December 2025
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 29 (3) , 18-27
Three-dimensional anatomical assessment of coronary artery lesions using optical coherence tomography
Background: The first and, thereby, decisive criterion for making a decision on myocardial revascularization is an anatomical severity of the coronary artery stenosis assessed by the decrease of lumen diameter ≥50 % (i.e., one-dimensionally). Intravascular imaging (IVI) enables to assess the stenosis by the decrease of the lumen area (twodimensionally) that is a more accurate anatomical assessment of the extent of lesions since it takes into account possible lumen deformations. Moreover, IVI provides ordered series of two-dimensional images and enables volumetric assessment of the degree of stenosis, considering both transverse and longitudinal lumen deformation, i.e., an even more accurate assessment of the stenosis severity. However, this capability of IVI is currently not fully utilized.Objective: The study was aimed at testing the hypothesis on thesuperiority of volumetric three-dimensional characteristics of stenosesobtained using simplified analysis of optical coherence tomography (OCT) data over standard two-dimensional and one-dimensional anatomical assessments for determining the severity of coronary lesions.Methods: This prospective clinical study included patients with chronic coronary artery disease (CAD) and a high risk of percutaneous coronary intervention (PCI) due to complex coronary lesions. Volumetric characteristics of the lesions were assessed by simplified analysis ofserial OCT images; the degree of the stenosis by area and diameter wasmeasured in standard way. The significance of the obtained anatomicaldata was compared by their relationship with the validated indicator of the risk of major adverse cardiovascular events (MACE) in patients with coronary artery disease undergoing PCI – SYNTAX score. The relationship was assessed using Pearson correlation analysis; the significance of the coefficients was assessed by Student’s t-criterion; p-value < 0.05 was considered statistically significant. Results: The study included 33 patients, of whom 5 were excluded dueto the inability to perform OCT without predilation. A significant positiverelationship was found between the volumetric degree of stenosis and the SYNTAX score (r = 0.339, p = 0.042) whereas the two-and onedimensional parameters, including the decrease of lumen area, failed to demonstrate such relationship (r = –0.067, p = 0.74).Conclusion: Volumetric stenosis assessments, in particular thevolumetric stenosis degree, obtained using simplified OCT data analysisare superior in assessing lesion severity and the risk of adverse PCI outcomes compared to existing standard area and diameter assessments, i.e., 2- and 1-dimensional assessments.
- 18 December 2025
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 29 (3) , 18-27
Open AccessThree-dimensional anatomical assessment of coronary artery lesions using optical coherence tomography
Background: The first and, thereby, decisive criterion for making a decision on myocardial revascularization is an anatomical severity of the coronary artery stenosis assessed by the decrease of lumen diameter ≥50 % (i.e., one-dimensionally). Intravascular imaging (IVI) enables to assess the stenosis by the decrease of the lumen area (twodimensionally) that is a more accurate anatomical assessment of the extent of lesions since it takes into account possible lumen deformations. Moreover, IVI provides ordered series of two-dimensional images and enables volumetric assessment of the degree of stenosis, considering both transverse and longitudinal lumen deformation, i.e., an even more accurate assessment of the stenosis severity. However, this capability of IVI is currently not fully utilized.Objective: The study was aimed at testing the hypothesis on thesuperiority of volumetric three-dimensional characteristics of stenosesobtained using simplified analysis of optical coherence tomography (OCT) data over standard two-dimensional and one-dimensional anatomical assessments for determining the severity of coronary lesions.Methods: This prospective clinical study included patients with chronic coronary artery disease (CAD) and a high risk of percutaneous coronary intervention (PCI) due to complex coronary lesions. Volumetric characteristics of the lesions were assessed by simplified analysis ofserial OCT images; the degree of the stenosis by area and diameter wasmeasured in standard way. The significance of the obtained anatomicaldata was compared by their relationship with the validated indicator of the risk of major adverse cardiovascular events (MACE) in patients with coronary artery disease undergoing PCI – SYNTAX score. The relationship was assessed using Pearson correlation analysis; the significance of the coefficients was assessed by Student’s t-criterion; p-value < 0.05 was considered statistically significant. Results: The study included 33 patients, of whom 5 were excluded dueto the inability to perform OCT without predilation. A significant positiverelationship was found between the volumetric degree of stenosis and the SYNTAX score (r = 0.339, p = 0.042) whereas the two-and onedimensional parameters, including the decrease of lumen area, failed to demonstrate such relationship (r = –0.067, p = 0.74).Conclusion: Volumetric stenosis assessments, in particular thevolumetric stenosis degree, obtained using simplified OCT data analysisare superior in assessing lesion severity and the risk of adverse PCI outcomes compared to existing standard area and diameter assessments, i.e., 2- and 1-dimensional assessments.
- Open Access
- 5 October 2025
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 40 (3) , 50-56
Serum fibrinogen level and platelet-to-lymphocyte ratio as predictors of vulnerable atherosclerotic plaque formation in coronary arteries in patients with coronary artery disease and arterial hypertension
Objective. It is well-established that rupture of lipid-rich atherosclerotic lesions in the coronary arteries (referred to as vulnerable, high-risk, or unstable plaques) with subsequent coronary artery thrombosis is the most common cause of acute coronary syndrome and sudden cardiac death. Vulnerable plaques are most accurately detected using optical coherence tomography (OCT). Given the high cost of OCT, an urgent task is to search for markers of the development of vulnerable atherosclerotic plaques in the coronary arteries based on routine examination data, which will allow developing effective strategies for the prevention of associated coronary events. In hypertensive patients potential markers may include indicators of systemic inflammation, but little information is available on this topic.Aim: To identify potential markers of vulnerable atherosclerotic plaques in coronary arteries in patients with stable coronary artery disease and hypertension based on routine laboratory testing.Material and Methods. The study included patients >18 years old, with a diagnosis of stable coronary artery disease and indications for OCT-guided PCI (extended/calcified/bifurcation lesions and/or diabetes), who gave informed consent to participate in the study. All patients underwent laboratory and instrumental examination in accordance with approved standards of medical care. A total of 30 patients were included in the study: aged 66.5±9.2 years (including 17 men); office BP 134.4±12.4/78.3±6.05 mmHg (systolic, SBP/ diastolic, DBP, respectively); type 2 diabetes mellitus (DM2) was detected in 30%; body mass index was 30.7±5.3 kg/m2.Results. According to OCT data, patients were divided into two groups: group 1 (n = 19) with the presence of vulnerable atherosclerotic plaque morphology (rich lipid core, lipid plaque with lipid arc expansion>180°, presence of macrophage clusters) and group 2 (n = 11) with atherosclerotic plaques without signs of vulnerability. The groups were comparable in terms of gender, age, blood pressure, antihypertensive, hypoglycemic and lipid-lowering therapy. However, patients in group 1 had statistically significantly higher levels of fibrinogen (3.39±0.86 vs. 2.75±0.45, p = 0.038), platelet-lymphocyte ratio (119.2±31.9 vs. 84.0±30, p = 0.006) and blood creatinine (88.3±13.2 vs. 76.7±7.8, p = 0.014). According to multivariate logistic regression analysis, blood fibrinogen and plateletlymphocyte ratio were independent markers of the presence of vulnerable atherosclerotic plaques.Conclusion. Platelet-lymphocyte ratio and blood fibrinogen levels, determined as part of a routine examination and reflecting increased activity of systemic inflammation, are markers of the development of vulnerable atherosclerotic plaques in the coronary arteries in patients with stable coronary artery disease and hypertension.
- 5 October 2025
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 40 (3) , 50-56
Open AccessSerum fibrinogen level and platelet-to-lymphocyte ratio as predictors of vulnerable atherosclerotic plaque formation in coronary arteries in patients with coronary artery disease and arterial hypertension
Objective. It is well-established that rupture of lipid-rich atherosclerotic lesions in the coronary arteries (referred to as vulnerable, high-risk, or unstable plaques) with subsequent coronary artery thrombosis is the most common cause of acute coronary syndrome and sudden cardiac death. Vulnerable plaques are most accurately detected using optical coherence tomography (OCT). Given the high cost of OCT, an urgent task is to search for markers of the development of vulnerable atherosclerotic plaques in the coronary arteries based on routine examination data, which will allow developing effective strategies for the prevention of associated coronary events. In hypertensive patients potential markers may include indicators of systemic inflammation, but little information is available on this topic.Aim: To identify potential markers of vulnerable atherosclerotic plaques in coronary arteries in patients with stable coronary artery disease and hypertension based on routine laboratory testing.Material and Methods. The study included patients >18 years old, with a diagnosis of stable coronary artery disease and indications for OCT-guided PCI (extended/calcified/bifurcation lesions and/or diabetes), who gave informed consent to participate in the study. All patients underwent laboratory and instrumental examination in accordance with approved standards of medical care. A total of 30 patients were included in the study: aged 66.5±9.2 years (including 17 men); office BP 134.4±12.4/78.3±6.05 mmHg (systolic, SBP/ diastolic, DBP, respectively); type 2 diabetes mellitus (DM2) was detected in 30%; body mass index was 30.7±5.3 kg/m2.Results. According to OCT data, patients were divided into two groups: group 1 (n = 19) with the presence of vulnerable atherosclerotic plaque morphology (rich lipid core, lipid plaque with lipid arc expansion>180°, presence of macrophage clusters) and group 2 (n = 11) with atherosclerotic plaques without signs of vulnerability. The groups were comparable in terms of gender, age, blood pressure, antihypertensive, hypoglycemic and lipid-lowering therapy. However, patients in group 1 had statistically significantly higher levels of fibrinogen (3.39±0.86 vs. 2.75±0.45, p = 0.038), platelet-lymphocyte ratio (119.2±31.9 vs. 84.0±30, p = 0.006) and blood creatinine (88.3±13.2 vs. 76.7±7.8, p = 0.014). According to multivariate logistic regression analysis, blood fibrinogen and plateletlymphocyte ratio were independent markers of the presence of vulnerable atherosclerotic plaques.Conclusion. Platelet-lymphocyte ratio and blood fibrinogen levels, determined as part of a routine examination and reflecting increased activity of systemic inflammation, are markers of the development of vulnerable atherosclerotic plaques in the coronary arteries in patients with stable coronary artery disease and hypertension.
- Open Access
- 5 October 2025
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 40 (3) , 94-104
Clinical, laboratory and instrumental correlations with the functional significance of coronary artery stenosis in patients with stable coronary artery disease and hypertension
Background. A significant proportion of patients with coronary artery disease (CAD) require myocardial revascularization. Arterial hypertension (AH), as a major risk factor for CAD, may influence the extent and severity of coronary artery (CA) lesions. However, visual assessment of coronary stenosis based on angiographic imaging does not always reflect their true hemodynamic significance. Therefore, the use of invasive functional assessment methods, such as the instantaneous wave-free ratio (iFR), is recommended for quantifying the ischemic potential of borderline stenosis. At present, there are no established clinical predictors for identifying functionally significant coronary lesions. Developing predictive models based on clinical, laboratory, and non-invasive imaging parameters may enhance decision-making regarding myocardial revascularization and the management of modifiable risk factors.Aim: To evaluate the associations between the functional significance of CA stenosis and clinical, laboratory, blood pressure (BP), and epicardial adipose tissue (EAT) parameters in patients with stable CAD and HT.Material and Methods. The study included 82 patients (56 men; mean age 66.1 ± 8.5 years) with stable CAD and HT, all of whom had borderline (50–90%) CA stenosis identified by coronary angiography. All participants underwent comprehensive clinical and laboratory assessment, transthoracic echocardiography, 24-hour ambulatory BP monitoring (ABPM), computed tomography (CT) for EAT volume and density evaluation, and iFR measurement to determine the functional significance of coronary stenosis.Results. Patients were divided into two groups based on iFR values: those with functionally significant stenosis (iFR ≤ 0.89; n = 58) and those without (iFR > 0.89; n = 24). Both groups were comparable in baseline clinical and laboratory parameters. Patients with functionally significant stenosis demonstrated significantly higher clinical systolic BP (SBP), 24-hour SBP, and pulse pressure; greater daytime SBP load; reduced heart rate variability; a higher percentage of blood monocytes; lower prevalence of abdominal obesity; and smaller left atrial (LA) size. Multivariate logistic regression analysis, confirmed by ROC analysis, identified clinical SBP, monocyte percentage, and LA size as independent predictors of functionally significant stenosis.Conclusion. In patients with stable CAD and HT, the presence of functionally significant CA stenosis is associated with elevated SBP, increased monocyte count, and smaller LA size.
- 5 October 2025
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 40 (3) , 94-104
Open AccessClinical, laboratory and instrumental correlations with the functional significance of coronary artery stenosis in patients with stable coronary artery disease and hypertension
Background. A significant proportion of patients with coronary artery disease (CAD) require myocardial revascularization. Arterial hypertension (AH), as a major risk factor for CAD, may influence the extent and severity of coronary artery (CA) lesions. However, visual assessment of coronary stenosis based on angiographic imaging does not always reflect their true hemodynamic significance. Therefore, the use of invasive functional assessment methods, such as the instantaneous wave-free ratio (iFR), is recommended for quantifying the ischemic potential of borderline stenosis. At present, there are no established clinical predictors for identifying functionally significant coronary lesions. Developing predictive models based on clinical, laboratory, and non-invasive imaging parameters may enhance decision-making regarding myocardial revascularization and the management of modifiable risk factors.Aim: To evaluate the associations between the functional significance of CA stenosis and clinical, laboratory, blood pressure (BP), and epicardial adipose tissue (EAT) parameters in patients with stable CAD and HT.Material and Methods. The study included 82 patients (56 men; mean age 66.1 ± 8.5 years) with stable CAD and HT, all of whom had borderline (50–90%) CA stenosis identified by coronary angiography. All participants underwent comprehensive clinical and laboratory assessment, transthoracic echocardiography, 24-hour ambulatory BP monitoring (ABPM), computed tomography (CT) for EAT volume and density evaluation, and iFR measurement to determine the functional significance of coronary stenosis.Results. Patients were divided into two groups based on iFR values: those with functionally significant stenosis (iFR ≤ 0.89; n = 58) and those without (iFR > 0.89; n = 24). Both groups were comparable in baseline clinical and laboratory parameters. Patients with functionally significant stenosis demonstrated significantly higher clinical systolic BP (SBP), 24-hour SBP, and pulse pressure; greater daytime SBP load; reduced heart rate variability; a higher percentage of blood monocytes; lower prevalence of abdominal obesity; and smaller left atrial (LA) size. Multivariate logistic regression analysis, confirmed by ROC analysis, identified clinical SBP, monocyte percentage, and LA size as independent predictors of functionally significant stenosis.Conclusion. In patients with stable CAD and HT, the presence of functionally significant CA stenosis is associated with elevated SBP, increased monocyte count, and smaller LA size.
- Open Access
- 25 August 2025
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (7) , 6243
Long-term effectiveness of renal denervation in patients with resistant hypertension: results of 5-year follow-up
Aim. To evaluate the long-term effectiveness of renal denervation (RDN) in reducing blood pressure (BP) and cardio- and nephroprotection in patients with resistant hypertension based on five-year follow-up.Material and methods. A total of 53 patients who completed a five-year follow-up period after RDN were examined (mean age 56,3±9,2 years, 23 men (43%), mean 24-hour BP (BP-24) — 168/94 mm Hg). Office and mean 24-hour BP were assessed. Left ventricular mass (LVM) were measured using echocardiography data. Renal function was evaluated using the estimated glomerular filtration rate (eGFR) (CKD-EPI), 24-hour urine volume, 24-hour urine protein and albumin excretion, daily K- and Na-cut. The primary endpoint of RDN efficacy was considered to be a decrease in systolic BP (SBP)-24. There were following secondary endpoints: achievement of target BP, proportion of responders (individuals with decrease in SBP-24 by 5 mm Hg or more), decrease in LVM, slowing of eGFR decline rate (change in eGFR 155,5 mm Hg), variability of SBP-24 (>5,5 mm Hg) and kaliuresis level (>27,2 mmol/l).Conclusion. RDN in patients with resistant HTN is accompanied by a stable 5-year antihypertensive effect without accelerating the renal function decline rate, as well as myocardial structural improvement in the form of a decrease in interventricular septal thickness. One of the pathophysiological mechanisms for BP reduction may be an increase in natriuresis, and its predictors are the initial levels of SBP-24, its variability, and 24-hour kaliuresis.
- 25 August 2025
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (7) , 6243
Open AccessLong-term effectiveness of renal denervation in patients with resistant hypertension: results of 5-year follow-up
Aim. To evaluate the long-term effectiveness of renal denervation (RDN) in reducing blood pressure (BP) and cardio- and nephroprotection in patients with resistant hypertension based on five-year follow-up.Material and methods. A total of 53 patients who completed a five-year follow-up period after RDN were examined (mean age 56,3±9,2 years, 23 men (43%), mean 24-hour BP (BP-24) — 168/94 mm Hg). Office and mean 24-hour BP were assessed. Left ventricular mass (LVM) were measured using echocardiography data. Renal function was evaluated using the estimated glomerular filtration rate (eGFR) (CKD-EPI), 24-hour urine volume, 24-hour urine protein and albumin excretion, daily K- and Na-cut. The primary endpoint of RDN efficacy was considered to be a decrease in systolic BP (SBP)-24. There were following secondary endpoints: achievement of target BP, proportion of responders (individuals with decrease in SBP-24 by 5 mm Hg or more), decrease in LVM, slowing of eGFR decline rate (change in eGFR 155,5 mm Hg), variability of SBP-24 (>5,5 mm Hg) and kaliuresis level (>27,2 mmol/l).Conclusion. RDN in patients with resistant HTN is accompanied by a stable 5-year antihypertensive effect without accelerating the renal function decline rate, as well as myocardial structural improvement in the form of a decrease in interventricular septal thickness. One of the pathophysiological mechanisms for BP reduction may be an increase in natriuresis, and its predictors are the initial levels of SBP-24, its variability, and 24-hour kaliuresis.
- Open Access
- 1 July 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (3) , 96-111
REVIEW OF MODERN PREDICTIVE MODELS OF MULTIPLE COMPLICATIONS AFTER PCI: THE ROLE OF MACHINE LEARNING AND TRADITIONAL APPROACHES
HighlightsThe first comparative review of modern models for predicting multiple PCI complications simultaneously, including those based on machine learning, is presented. The advantage of machine learning models (especially XGBoost) is demonstrated, which, even when using a single data set, have high accuracy and are able to take into account complex nonlinear factors that were not previously taken into account by traditional risk scales. The top 3 models have been identified that can simultaneously predict multiple outcomes without duplicating variables and it is what lays the foundation for more effective and versatile clinical tools. AbstractModern models for predicting complications of percutaneous coronary interventions (PCI) are rapidly evolving under the influence of new machine learning (ML) technologies. This research presents a comparative review of existing methods aimed at simultaneously predicting multiple complications of PCI (death, bleeding, acute kidney failure, etc.). The study compares traditional risk stratification scales (such as NCDR Cath-PCI, CART VA, and others) with modern ML algorithms.A keyword search in the PubMed database over the past 10 years identified 2 667 publications related to PCI complication prediction. After excluding publications that did not provide sufficient information regarding study design, model construction, and data analysis, those based on virtual data analysis, single-outcome prediction studies, as well as reviews and clinical case reports, 9 of the most relevant studies were selected. These studies covered large registries from the USA, Japan, and international database.Despite the diversity of approaches, only a limited number of models are formally capable of simultaneously predicting multiple complications based on a single set of variables. Moreover, in most studies, the use of ML (particularly XGBoost) increased accuracy compared to traditional methods.The results of the study confirm the potential of machine learning in the multi-outcome risk assessment of PCI. However, the effective use of these models in clinical practice requires reliable external validation, adaptation to local conditions, and consideration of technological innovations (such as intravascular imaging and invasive physiology). The development of ML-based prediction methods that meet these criteria will significantly improve the accuracy of PCI risk stratification, optimize procedural performance, and enhance patient outcomes in ischemic heart disease. A natural extension of this methodology is the inclusion of intravascular imaging and invasive physiology data in the models.
- 1 July 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (3) , 96-111
Open AccessREVIEW OF MODERN PREDICTIVE MODELS OF MULTIPLE COMPLICATIONS AFTER PCI: THE ROLE OF MACHINE LEARNING AND TRADITIONAL APPROACHES
HighlightsThe first comparative review of modern models for predicting multiple PCI complications simultaneously, including those based on machine learning, is presented. The advantage of machine learning models (especially XGBoost) is demonstrated, which, even when using a single data set, have high accuracy and are able to take into account complex nonlinear factors that were not previously taken into account by traditional risk scales. The top 3 models have been identified that can simultaneously predict multiple outcomes without duplicating variables and it is what lays the foundation for more effective and versatile clinical tools. AbstractModern models for predicting complications of percutaneous coronary interventions (PCI) are rapidly evolving under the influence of new machine learning (ML) technologies. This research presents a comparative review of existing methods aimed at simultaneously predicting multiple complications of PCI (death, bleeding, acute kidney failure, etc.). The study compares traditional risk stratification scales (such as NCDR Cath-PCI, CART VA, and others) with modern ML algorithms.A keyword search in the PubMed database over the past 10 years identified 2 667 publications related to PCI complication prediction. After excluding publications that did not provide sufficient information regarding study design, model construction, and data analysis, those based on virtual data analysis, single-outcome prediction studies, as well as reviews and clinical case reports, 9 of the most relevant studies were selected. These studies covered large registries from the USA, Japan, and international database.Despite the diversity of approaches, only a limited number of models are formally capable of simultaneously predicting multiple complications based on a single set of variables. Moreover, in most studies, the use of ML (particularly XGBoost) increased accuracy compared to traditional methods.The results of the study confirm the potential of machine learning in the multi-outcome risk assessment of PCI. However, the effective use of these models in clinical practice requires reliable external validation, adaptation to local conditions, and consideration of technological innovations (such as intravascular imaging and invasive physiology). The development of ML-based prediction methods that meet these criteria will significantly improve the accuracy of PCI risk stratification, optimize procedural performance, and enhance patient outcomes in ischemic heart disease. A natural extension of this methodology is the inclusion of intravascular imaging and invasive physiology data in the models.
- Open Access
- 27 December 2024
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 28 (4) , 18-32
Aspiration thrombectomy for the treatment of acute myocardial infarction in the light of critical analysis of contemporary trials
Objective: The study was aimed at assessing the available data on the efficacy and safety of thromboaspiration in acute coronary syndrome and its prospects for more frequent using in routine clinical practice. Methods: A search was performed in the Medline (PubMed), Cochrane Library and Web of Science databases for the period from 2000 to 2024 using the following keywords: “thrombectomy”, “thrombus aspiration”, “thromboaspiration” and “myocardial infarction”. Randomized controlled trials, prospective cohort and registry studies, and meta-analyses were included in the study, while experimental studies and studies with small samples (less than 50 patients) were excluded. The criteria for the efficacy of thromboaspiration itself were critically analyzed, as well as the impact of the device and its design on the efficacy and safety of thromboaspiration were assessed.Results: Of the 230 search results, 45 original publications that met the selection criteria were included in the review. Most studies assessing the efficacy/safety of therapy did not take into account the fact that 20-30% of thromboaspiration from coronary arteries were technically unsuccessful that is quite enough to underestimate its efficacy.Conclusion: The probable reason for the inconsistent results of thromboaspiration trials is high proportion of cases of technically unsuccessful outcomes related to the failure of extracting thrombotic contents from the aspiration catheter. Thromboaspiration is an etiological method for treating acute coronary artery thrombosis, and optimization of the design of thromboaspiration catheters and surgical techniques can significantly improve its efficacy and fully reveal the potential of this method for treating myocardial infarction. Received 25 September 2024. Revised 29 November 2024. Accepted 2 December 2024. FundingThe study did not have sponsorship. Conflict of interestThe authors declare no conflict of interest. Contribution of the authorsConception and study design: E.S. Gergert, S.E. Pekarskiy,A.E. Baev, M.G. Tarasov, I.V. Suslov, A.A. Gorokhovsky, S.M. Sultanov, Yu.I. BogdanovData collection and analysis: E.S. Gergert, S.E. Pekarskiy,I.V. Suslov, A.A. GorokhovskyDrafting the article: E.S. Gergert, I.V. Suslov, A.A. GorokhovskyCritical revision of the article: E.S. Gergert, S.E. Pekarskiy, A.E. Baev, M.G. Tarasov, I.V. Suslov, A.A. Gorokhovsky, S.M. Sultanov, Yu.I. BogdanovFinal approval of the version to be published: E.S. Gergert, S.E. Pekarskiy, A.E. Baev, M.G. Tarasov, I.V. Suslov, A.A. Gorokhovsky, S.M. Sultanov, Yu.I. Bogdanov
- 27 December 2024
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 28 (4) , 18-32
Open AccessAspiration thrombectomy for the treatment of acute myocardial infarction in the light of critical analysis of contemporary trials
Objective: The study was aimed at assessing the available data on the efficacy and safety of thromboaspiration in acute coronary syndrome and its prospects for more frequent using in routine clinical practice. Methods: A search was performed in the Medline (PubMed), Cochrane Library and Web of Science databases for the period from 2000 to 2024 using the following keywords: “thrombectomy”, “thrombus aspiration”, “thromboaspiration” and “myocardial infarction”. Randomized controlled trials, prospective cohort and registry studies, and meta-analyses were included in the study, while experimental studies and studies with small samples (less than 50 patients) were excluded. The criteria for the efficacy of thromboaspiration itself were critically analyzed, as well as the impact of the device and its design on the efficacy and safety of thromboaspiration were assessed.Results: Of the 230 search results, 45 original publications that met the selection criteria were included in the review. Most studies assessing the efficacy/safety of therapy did not take into account the fact that 20-30% of thromboaspiration from coronary arteries were technically unsuccessful that is quite enough to underestimate its efficacy.Conclusion: The probable reason for the inconsistent results of thromboaspiration trials is high proportion of cases of technically unsuccessful outcomes related to the failure of extracting thrombotic contents from the aspiration catheter. Thromboaspiration is an etiological method for treating acute coronary artery thrombosis, and optimization of the design of thromboaspiration catheters and surgical techniques can significantly improve its efficacy and fully reveal the potential of this method for treating myocardial infarction. Received 25 September 2024. Revised 29 November 2024. Accepted 2 December 2024. FundingThe study did not have sponsorship. Conflict of interestThe authors declare no conflict of interest. Contribution of the authorsConception and study design: E.S. Gergert, S.E. Pekarskiy,A.E. Baev, M.G. Tarasov, I.V. Suslov, A.A. Gorokhovsky, S.M. Sultanov, Yu.I. BogdanovData collection and analysis: E.S. Gergert, S.E. Pekarskiy,I.V. Suslov, A.A. GorokhovskyDrafting the article: E.S. Gergert, I.V. Suslov, A.A. GorokhovskyCritical revision of the article: E.S. Gergert, S.E. Pekarskiy, A.E. Baev, M.G. Tarasov, I.V. Suslov, A.A. Gorokhovsky, S.M. Sultanov, Yu.I. BogdanovFinal approval of the version to be published: E.S. Gergert, S.E. Pekarskiy, A.E. Baev, M.G. Tarasov, I.V. Suslov, A.A. Gorokhovsky, S.M. Sultanov, Yu.I. Bogdanov
- Open Access
- 30 September 2024
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 13 (3) , 37-46
PITFALLS IN USING INTRAVASCULAR IMAGING DURING PCI: SIZING THE STENT ACCORDING TO MEAN ARTERIAL LUMEN DIAMETER MAY RESULT IN STENT UNDEREXPANSION
HighlightsContemporary algorithms for optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) are easy to learn and understand, however, these algorithms are mostly declarative, and not substantiated in practice. In particular, using the mean reference lumen diameter may result in underestimation of the optimal stent size in relation to the degree of stenosis, i.e., the difference between the minimum and maximum diameters (lumen asymmetry), whereas choosing a stent based on the mean lumen diameter leads to stent underexpansion. Aim. To assess whether choosing a stent size based on the mean lumen diameter of the reference segment of the artery may result in its underexpansion.Methods. The prospective cohort study included patients with chronic coronary artery disease and complex lesion anatomy who underwent high-risk OCT-guided PCI. Based on the OCT results, the distal and proximal reference segments were determined, in which the minimum and maximum diameters were measured, followed by calculating the mean lumen diameter, which was further used for stent selection. Based on the results of repeated OCT after stent implantation, the degree of stent expansion was assessed. The expected relationship between the degree of stent expansion and the baseline lumen asymmetry was assessed by correlation analysis. Linear regression was used to determine the asymmetry threshold corresponding to clinically relevant stent expansion of 80%.Results. Overall, 24 patients were enrolled, 3 of them were excluded because of inability to perform OCT without lesion predilatation. On average, the maximum and minimum diameters of the reference lumen according to OCT were 2.87 ± 0.66 mm and 1.85 ± 0.44 mm, respectively. The ratio between minimum and maximum diameter was 0.35 ± 0.09. The mean diameter was 2.30 ± 0.51 mm, the difference between the maximum and mean diameters was 0.61 ± 0.28 mm. The criterion of stent expansion ≥ 80% was achieved in 6 cases (28.6%). The correlation analysis has shown a statistically significant inversely proportional dependence of the relative stent expansion on the baseline lumen asymmetry (the difference between the maximum and minimum diameters (r = –0.41, p = 0.032), while clinically relevant stent expansion ≥ 80% was observed with a relative difference in diameters of less than 30%Conclusion. In case of significant lumen asymmetry choosing a stent diameter based on the mean lumen diameter is associated with stent uderexpansion.
- 30 September 2024
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 13 (3) , 37-46
Open AccessPITFALLS IN USING INTRAVASCULAR IMAGING DURING PCI: SIZING THE STENT ACCORDING TO MEAN ARTERIAL LUMEN DIAMETER MAY RESULT IN STENT UNDEREXPANSION
HighlightsContemporary algorithms for optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) are easy to learn and understand, however, these algorithms are mostly declarative, and not substantiated in practice. In particular, using the mean reference lumen diameter may result in underestimation of the optimal stent size in relation to the degree of stenosis, i.e., the difference between the minimum and maximum diameters (lumen asymmetry), whereas choosing a stent based on the mean lumen diameter leads to stent underexpansion. Aim. To assess whether choosing a stent size based on the mean lumen diameter of the reference segment of the artery may result in its underexpansion.Methods. The prospective cohort study included patients with chronic coronary artery disease and complex lesion anatomy who underwent high-risk OCT-guided PCI. Based on the OCT results, the distal and proximal reference segments were determined, in which the minimum and maximum diameters were measured, followed by calculating the mean lumen diameter, which was further used for stent selection. Based on the results of repeated OCT after stent implantation, the degree of stent expansion was assessed. The expected relationship between the degree of stent expansion and the baseline lumen asymmetry was assessed by correlation analysis. Linear regression was used to determine the asymmetry threshold corresponding to clinically relevant stent expansion of 80%.Results. Overall, 24 patients were enrolled, 3 of them were excluded because of inability to perform OCT without lesion predilatation. On average, the maximum and minimum diameters of the reference lumen according to OCT were 2.87 ± 0.66 mm and 1.85 ± 0.44 mm, respectively. The ratio between minimum and maximum diameter was 0.35 ± 0.09. The mean diameter was 2.30 ± 0.51 mm, the difference between the maximum and mean diameters was 0.61 ± 0.28 mm. The criterion of stent expansion ≥ 80% was achieved in 6 cases (28.6%). The correlation analysis has shown a statistically significant inversely proportional dependence of the relative stent expansion on the baseline lumen asymmetry (the difference between the maximum and minimum diameters (r = –0.41, p = 0.032), while clinically relevant stent expansion ≥ 80% was observed with a relative difference in diameters of less than 30%Conclusion. In case of significant lumen asymmetry choosing a stent diameter based on the mean lumen diameter is associated with stent uderexpansion.